Individualized dosing regimens in children based on population PKPD modelling: Are we ready for it?
- 30 August 2011
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 415 (1-2), 9-14
- https://doi.org/10.1016/j.ijpharm.2011.02.056
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Microanalysis of β-Lactam Antibiotics and Vancomycin in Plasma for Pharmacokinetic Studies in NeonatesAntimicrobial Agents and Chemotherapy, 2009
- Covariates of tramadol disposition in the first months of lifeBritish Journal of Anaesthesia, 2008
- Developing paediatric medicines: identifying the needs and recognizing the challengesJournal of Pharmacy and Pharmacology, 2007
- Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling: Biophase Distribution, Receptor Theory, and Dynamical Systems AnalysisAnnual Review of Pharmacology and Toxicology, 2007
- Are Population Pharmacokinetic and/or Pharmacodynamic Models Adequately Evaluated?Clinical Pharmacokinetics, 2007
- Postoperative pain in the neonate: age-related differences in morphine requirements and metabolismIntensive Care Medicine, 2003
- Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infantsBritish Journal of Anaesthesia, 2003
- Nonlinear dynamics and chaos theory: concepts and applications relevant to pharmacodynamics.Pharmaceutical Research, 2001
- Survey of unlicensed and off label drug use in paediatric wards in European countriesBMJ, 2000
- Cytochrome P450 3AClinical Pharmacokinetics, 1999